3.4.24.62	Ca2+	weak, 1 mM, peptide I as substrate	15	
3.4.24.62	Cd2+	weak, 0.1 mM, peptide I as substrate	52	
3.4.24.62	Cys-Lys-Gly-Gly-Lys-Arg-Ala-Val-Lys-Cys	-	92988	
3.4.24.62	D-Arg12 derivate of pro-oxytocin/neurophysin (1-20)	-	60927	
3.4.24.62	Divalent cation chelators	-	98466	
3.4.24.62	EDTA	peptide I as substrate; strong, 2.5 mM	21	
3.4.24.62	EDTA	strong, 2.5 mM	21	
3.4.24.62	EDTA	-	21	
3.4.24.62	EDTA	inhibits at millimolar concentrations	21	
3.4.24.62	EGTA	peptide I as substrate; strong, 2.5 mM	173	
3.4.24.62	EGTA	strong, 2.5 mM	173	
3.4.24.62	EGTA	inhibits at millimolar concentrations	173	
3.4.24.62	Leu-Gly-Gly-Lys-Arg-Ala-Val-Lys-Asp	-	93906	
3.4.24.62	additional information	Mn2+, Mg2+, Cu2+; no inhibition by PMSF, pepstatin	2	
3.4.24.62	additional information	no inhibition by PMSF, pepstatin	2	
3.4.24.62	additional information	pro-oxytocin/neurophysin derived peptides (overview)	2	
3.4.24.62	additional information	[D-Lys11]-pro-oxytocin/neurophysin(1-20), Gly-Gly-Lys-D-Arg-Ala-Val, Cys-Pro-Leu-Gly-Gly-Lys-D-Arg-Ala-Val; no inhibition by PMSF, pepstatin	2	
3.4.24.62	additional information	not inhibited by PMSF, apronitin or pepstatin	2	
3.4.24.62	p-(chloromercuri)-benzenesulfonic acid	partially sensitive to	60926	
3.4.24.62	p-chloromercuriphenylsulfonic acid	2.5 mM; peptide I as substrate	1416	
3.4.24.62	p-chloromercuriphenylsulfonic acid	2.5 mM	1416	
3.4.24.62	PCMB	2.5 mM; peptide I as substrate	78	
3.4.24.62	PCMB	2.5 mM	78	
3.4.24.62	PCMB	partially sensitive to	78	
3.4.24.62	Zn2+	1 mM, peptide I as substrate	14	
3.4.24.62	[D-Arg12]-Pro-oxytocin/neurophysin(1-20)	peptide I as substrate	29225	
3.4.24.62	[D-Arg12]-Pro-oxytocin/neurophysin(1-20)	kinetics; peptide I as substrate	29225